Secretase
These proteolytic enzymes are involved in the proteolytic processing of amyloid precursor protein, which is implicated in the pathogenesis of Alzheimer's disease.
Secretase research is vital for understanding disease mechanisms and developing targeted therapies.
PubComapre.ai optimizes this research by leveraging AI-driven protocol comparisons to locate the best Secretase protocols from literature, preprints, and patents, enhancing reproducibility and accuracy.
Experince seamless Secretase research with the power of PubComapre.ai.
Most cited protocols related to «Secretase»
To compare model refinement against deposited EMDB entries and LocScale maps, PDB-deposited coordinate models associated with the respective EMDB entry were randomly perturbed by applying atom shifts of up to 0.4 Å to serve as starting models. Five iterations of local and global real-space coordinate refinement against the respective EMDB or LocScale map were each followed by refinement of atomic B-factors in reciprocal space. As above, secondary structure restraints, resolution-dependent weights and NCS restraints were employed. EMRinger scores were computed using phenix.em_ringer (Barad et al., 2015 (link)); all other validation scores were obtained using MOLPROBITY (Chen et al., 2010 (link)). All cross-validation FSC and real-space correlations were computed against the original reconstruction and the deposited EMDB map, respectively.
Pharmacological inhibition of Notch signaling in Hes1-EmGFPSAT mice was achieved by intraperitoneal administration of the γ-secretase inhibitor dibenzazepine (DBZ: 20 µM/kg body weight in 0.5% HPMC, 0.1% w/v NP40 in water; Calbiochem). Adult mice were injected with DBZ for 4 consecutive days and analyzed 3–4 days after the last injection.
Polyclonal anti-PS1-NTF (B19.2), -CTF (B32.1) and -TLN (B36.1) have been described previously (Annaert et al., 2001 (link)). B63.1 and B59.1 were generated using a synthetic peptide mimicking the final 16 and 18 amino acids of APP and nicastrin, respectively, coupled to KLH (Pierce Chemical Co.). Mab 9C3 against nicastrin was produced by immunizing the same peptide in balb/c mice followed by generation of a hybridoma cell line according to established procedures. We acknowledge the antibody gifts of anti-calnexin (A. Helenius, ETH Zurich, Zurich, Switzerland), anti-ergic-53 (J. Saraste, University of Bergen, Bergen, Norway) -LC3 (T. Yoshimori, National Institute of Genetics, Shizuoka-ken, Japan), -Apg12 (N. Mizushima, National Institute for Basic Biology, Okazaki, Japan), PIP2 (G. Hammond, Cancer Research Institute, London, UK), -LBPA (J. Gruenberg, University of Geneva, Geneva, Switzerland), and -APP COOH terminus (c 1/6.1; P. Mathews, Nathan Kline Institute, Orangeburg, NY). Mabs to Lamp-2 (Abl-93) were obtained from Developmental Studies Hybridoma Bank (Iowa City, Iowa); anti-synaptophysin (cl.7.2) and anti-PS1-CTF (mAb 5.2) were from R. Jahn (MPI-Göttingen, Göttingen, Germany) and B. Cordell (Scios Inc., Sunnyvale, CA). mAbs to GM130 and EEA1 were from BD Biosciences, the transferrin receptor from Zymed Laboratories, β-COP from Sigma-Aldrich, and BIP from StressGen Biotechnologies.
Most recents protocols related to «Secretase»
Example 1
We demonstrated the expression of STAT1 was higher in AD cases than the aged matched control cases (
To understand whether the activation of STAT1 pathway was causal for the pathogenesis of AD, or was an consequence of neuro-inflammation in late stage of AD, we crossed STAT1−/− mice with APP/PS1 mice to generate AD mice with STAT1−/− background. APP/PS1/STAT1−/− mice, and their littermate controls of APP/PS1 genotype were kept to 3-4 months and sacrificed for histological examination of Aβ deposition. Surprisingly, we found consistent reduction in Aβ number as well as areas occupied by Aβ in Stat1−/− mice (
Example 4
Multiple mechanism could contribute to the increase of cellular APP following 25-OHC treatment. However, our mouse data suggested both the synthesis and degradation of APP were normal: the expression of APP was similar, and the enzymes for APP cleavage was also comparable (
We went on to check the trafficking of APP protein. Surface APP were labeled by antibody, and cells were put back to incubator and fixed at different time point for staining. In untreated cells, APP quickly went to specific compartment in the cell, and within 6 hours, the signal disappeared, while in the 25-OHC treated cells, the trafficking of APP was slower (
Top products related to «Secretase»
More about "Secretase"
These enzymes, classified as α-secretase, β-secretase, and γ-secretase, cleave proteins and are crucial for understanding disease mechanisms and developing targeted therapies.
Secretase research is vital for advancing our understanding of disease pathways and exploring potential treatment options.
PubCompare.ai, a powerful AI-driven platform, optimizes this research by facilitating the comparison of Secretase-related protocols from literature, preprints, and patents.
This enables researchers to identify the best protocols, enhancing reproducibility and accuracy in their studies.
By leveraging the power of AI, PubCompare.ai helps researchers seamlessly navigate the vast landscape of Secretase research.
They can easily locate and compare the optimal Secretase-related protocols, including those involving DMSO, FBS, Lipofectamine 2000, β-secretase activity kit, DAPT, SensoLyte 520 TACE (α-secretase) activity assay kit, DMEM, Neurobasal medium, Laminin, and LY411575.
This streamlined approach empowers researchers to make informed decisions and advance their Secretase-focused investigations with greater efficiency and precision.
Experince the power of PubCompare.ai in your Secretase research journey, where you can effortlessly identify the most effective protocols and enhance the reproducibility and accuracy of your findings.